TORONTO, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Ascendant Resources Inc. (TSX:ASND) (OTCQX:ASDRF) (FRA:2D9) ("Ascendant" or the "Company”) reports that operations at its El Mochito mine in Honduras are continuing normally despite uncertainty following the General Elections h...Read More
COPENHAGEN, Denmark, Nov.21, 2017(GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs in rare diseases, today announced that the company will participate in an upcoming inves...Read More
- Phase 3 Program for TransCon Growth Hormone Advances and TransCon PTH Enters the Clinic - - Conference Call Today at 4:30 p.m. Eastern Time - COPENHAGEN, Denmark, Nov.16, 2017(GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical company that utilizes its innovative TransCo...Read More
Adjusted EBITDA1 of $1.3 million in OctoberMilled production increased to 2,184 tpd; up 67% year to dateNew fleet arrivals to drive production growth in Q4 2017 and 2018 TORONTO, Nov.14, 2017(GLOBE NEWSWIRE) -- Ascendant Resources Inc. (TSX:ASND) (OTCQX:ASDRF) (FRA:2D9) ("Ascendant" or the "Comp...Read More
Highlights Include: Net income of $821,000 and $0.01/shareThird consecutive month of positive adjusted EBITDA1; $2.4 million total for Q3 201775% increase in revenue versus Q2 2017Operating cash flow before changes in working capital of $2.3 million; Free cash flow expected before the end of Q4M...Read More
TORONTO, Nov.02, 2017(GLOBE NEWSWIRE) -- Ascendant Resources Inc. (TSX:ASND) (OTCQX:ASDRF) (FRA:2D9) ("Ascendant" or the "Company") announced today that it plans to release its third quarter 2017 results after the market close on Monday, November 13, 2017. Management will host a conference call...Read More
COPENHAGEN, Denmark, Nov.02, 2017(GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs in rare diseases, today announced that the company will hold a conference call and live...Read More
TORONTO, Oct.19, 2017(GLOBE NEWSWIRE) -- Asian Mineral Resources Limited ("AMR" or the "Company") (TSXV:ASN) today announces that its Board of Directors (the "Board") has initiated a strategic review process to explore its options with regard to the Ban Phuc Nickel Mine in Vietnam with the goal o...Read More
Milled production for Q3 increased by 17% against Q2 2017 averaging 1,934 tpd; September milled production increased by 8% versus August 2017 averaging 2,055 tpdFree cash flows expected imminentlyQ3 performance expected to support a strong Q4 and year-end exit rate that should drive robust 2018...Read More
TORONTO, Oct. 16, 2017 /CNW/ - Chris Buncic, President and CEO, Ascendant Resources Inc. (ASND), joined Shaun McIver, Chief Client Officer, Equity Capital Markets, TMX Group, to open the market. Ascendant Resources Inc. is a mining company focused on its producing El Mochito zinc, silver and lead...Read More
ZnEq grades proving to be consistently above current mining gradeKey Highlights*: (true and apparent widths): Exploration Areas in 2017 Infill HolesHOLE 10875 - 5.5m at 45.5% ZnEq, 5.2% zinc, 2.7% lead, 2,297 g/t silver and 0.98% copperHOLE 10887 - 23.4m at 7.7% ZnEq....Read More
TORONTO, Sept.28, 2017(GLOBE NEWSWIRE) -- Ascendant Resources Inc. (TSX:ASND) (OTCQX:ASDRF) (FRA:2D9) ("Ascendant" or the "Company") is pleased to announce the appointment of Ms. Petra Decher, CPA, CA to the Company's Board of Directors and Mr. Stephen Shefsky to the position of Lead Director of...Read More
COPENHAGEN, Denmark, Sept.27, 2017(GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a clinical stage biopharmaceutical company, today announced the pricing of its underwritten public offering of 3,800,000 American Depositary Shares ("ADSs"), each of which represents one ordinary share of As...Read More
COPENHAGEN, Denmark, Sept.26, 2017(GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs in rare diseases, announced today that it has dosed subjects in a phase 1 trial of Tran...Read More
COPENHAGEN, Denmark, Sept.26, 2017(GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a clinical stage biopharmaceutical company, today announced that it has commenced an underwritten public offering of $125,000,000 of American Depositary Shares ("ADSs"), each of which represents one ordina...Read More
Second consecutive month of positive adjusted EBITDATonnes milled increased to 1,903 tpd, up 9.8% from Q2 average and 53% from January 2017Fleet renewal in-process with new equipment orderedTORONTO, Sept.20, 2017(GLOBE NEWSWIRE) -- Ascendant Resources Inc. (TSX:ASND) (OTCQX:ASDRF) (FRA:2D9) ("As...Read More
TORONTO, Sept.13, 2017(GLOBE NEWSWIRE) -- Ascendant Resources Inc. (TSX:ASND) (OTCQX:ASDRF) (FRA:2D9) ("Ascendant" or the "Company") is pleased to announce the launch of its 360 ? virtual tour of the El Mochito Mine located in Honduras. The El Mochito Mine's virtual tour provides an in-depth view...Read More
TORONTO, ONTARIO--(Marketwired - Sept. 5, 2017) - Asian Mineral Resources Limited ("AMR" or the "Company") (TSX VENTURE:ASN) today announces that it has completed its Technical Report supporting the potential of its regional exploration prospects at the Company's 90% owned T...Read More
NEW YORK, Sept. 5, 2017 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced Ascendant Resources Inc. (TSX: ASND; OTCQX: ASDRF), a mining company focused on operations in Honduras, has qualified to trade on the...Read More
TORONTO, Sept.05, 2017(GLOBE NEWSWIRE) -- Ascendant Resources Inc. (TSX:ASND) (OTCQX:ASDRF) (FRA:2D9) ("Ascendant" or the "Company") announces that effective immediately its common shares have commenced trading in the United States under the symbol "ASDRF" on the OTCQX (R) Best Market ("OTCQX")....Read More